We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

Back to rankings

81 hedge funds and large institutions have $396M invested in Aratana Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,500% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 1

244% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 9

76% more funds holding

Funds holding: 46 → 81 (+35)

73% more capital invested

Capital invested by funds: $229M → $396M (+$167M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
81
Holders Change
+35
Holders Change %
+76.09%
% of All Funds
2.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
36
Increased
31
Reduced
9
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$31.4M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$16.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$16.6M
4
DM
Deerfield Management
New York
+$15.8M
5
BC
Broadfin Capital
New York
+$13.4M

Top Sellers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
-$31.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$13M
3
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
-$2M
4
BA
BlackRock Advisors
Delaware
-$348K
5
JP Morgan Chase
JP Morgan Chase
New York
-$244K
Name Holding Trade Value Shares
Change 		Change in
Stake
Lazard Asset Management
26
Lazard Asset Management
New York
$4.63M +$5M +249,459 New
NIP
27
Nicholas Investment Partners
California
$4.49M +$4.84M +241,706 New
HCMT
28
Highland Capital Management (Texas)
Texas
$4.25M +$4.59M +229,004 New
BFA
29
BlackRock Fund Advisors
California
$4.19M +$900K +44,899 +25%
VAM
30
Visium Asset Management
New York
$2.88M +$3.11M +155,236 New
HHC
31
Hutchin Hill Capital
New York
$2.78M +$751K +37,500 +33%
GPGA
32
Grandeur Peak Global Advisors
Utah
$2.42M +$2.61M +130,100 New
State Street
33
State Street
Massachusetts
$2.31M +$982K +48,991 +65%
Northern Trust
34
Northern Trust
Illinois
$2.05M +$380K +18,955 +21%
CS
35
Credit Suisse
Switzerland
$2.04M +$2.2M +109,940 New
Millennium Management
36
Millennium Management
New York
$1.86M +$679K +33,868 +51%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$1.75M +$1.21M +60,226 +176%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.52M +$1.02M +50,995 +165%
Alyeska Investment Group
39
Alyeska Investment Group
Illinois
$1.5M +$1.62M +80,893 New
WSA
40
Wall Street Associates
California
$1.4M +$1.51M +75,297 New
Creative Planning
41
Creative Planning
Kansas
$970K +$1.05M +52,269 New
FLAM
42
First Light Asset Management
Minnesota
$914K -$101K -5,026 -9%
Deutsche Bank
43
Deutsche Bank
Germany
$657K +$538K +26,870 +312%
Mariner
44
Mariner
Kansas
$544K – – –
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$538K +$581K +28,990 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$537K +$755K +37,670 New
WMSA
47
Weiss Multi-Strategy Advisers
New York
$464K +$501K +25,000 New
BIM
48
BlackRock Investment Management
Delaware
$423K +$79.2K +3,952 +21%
TCIM
49
TIAA CREF Investment Management
New York
$417K +$116K +5,768 +35%
RJA
50
Raymond James & Associates
Florida
$405K +$437K +21,800 New
1
2
3 4

PETX Hedge Fund Activity: Q1 2014 in Review

81 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q1 2014, worth a combined $396M — up 73% from $229M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new PETX positions and 1 closed out — a net gain of 35 holders — while 31 added to existing stakes and 9 trimmed.

The largest buyer was Franklin Resources, adding an estimated $31.4M. The largest seller was MPM Asset Management, cutting an estimated $31.3M.

  • 81 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q1 2014, up from 46 in Q4 2013.
  • Funds reported $396M of Aratana Therapeutics, Inc. stock for Q1 2014, up 73% quarter-over-quarter.
  • 36 funds opened new Aratana Therapeutics, Inc. positions in Q1 2014 and 1 closed out, a net change of +35 holders.
  • The largest Aratana Therapeutics, Inc. buyer in Q1 2014 was Franklin Resources, an estimated $31.4M added.
  • The largest Aratana Therapeutics, Inc. seller in Q1 2014 was MPM Asset Management, an estimated $31.3M sold.

Based on aggregated 13F filings for Q1 2014.